Sarcoma
Welcome,         Profile    Billing    Logout  
 554 Companies   303 Products   303 Products   167 Mechanisms of Action   1501 Trials   136971 News 


«12...15101511151215131514151515161517151815191520...17791780»
  • ||||||||||  Journal:  Myositis ossificans in the infraspinatus muscle: The key to diagnosis. (Pubmed Central) -  Dec 5, 2019   
    The results from the present study demonstrated that part of patients GrCTs exhibited TFE3 overexpression, which suggested that this may not be derived from gene rearrangement. The zone phenomenon is the most important diagnostic feature in differentiating myositis ossificans from malignancies such as osteosarcomas, which calcify from the center to the periphery and its presence in our late-stage lesion was the key to diagnosis.
  • ||||||||||  Clinical, Journal:  Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis. (Pubmed Central) -  Dec 5, 2019   
    The zone phenomenon is the most important diagnostic feature in differentiating myositis ossificans from malignancies such as osteosarcomas, which calcify from the center to the periphery and its presence in our late-stage lesion was the key to diagnosis. Immunophenotyping is critical to the diagnosis of MS, as it can be difficult to differentiate from other diagnoses including lymphoma using conventional light microscopy.
  • ||||||||||  Journal:  Dataset of breakthrough time for various modified sand materials using Rhodamine-B as an adsorbate. (Pubmed Central) -  Dec 5, 2019   
    All these data is a combination of three variables that were studied: a) concentration of Rhodamine-B (1 mg/L, 5 mg/L and 10 mg/L), b) flow velocity of Rhodamine-B spiked water (2 mL/min, 5 mL/min and 10 mL/min) and c) bed height (7.5 cm, 10 cm, and 12.5 cm). At any bed height, the breakthrough time of graphitized sand (brewery sugar coated, GS1) was found to be 3-4 times higher than the second best adsorbent, i.e., manganese dioxide coated on GS1.
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial completion date:  Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  Dec 5, 2019   
    P2,  N=53, Active, not recruiting, 
    At any bed height, the breakthrough time of graphitized sand (brewery sugar coated, GS1) was found to be 3-4 times higher than the second best adsorbent, i.e., manganese dioxide coated on GS1. Trial completion date: Dec 2019 --> Mar 2020
  • ||||||||||  IM49: Diagnosing Soft Tissue Sarcomas on Core Biopsy: A Challenge in the Challenge (LACC 507) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_440;    
    USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Physicians can earn a maximum of 1.5 SAM/Part II credit hours.
  • ||||||||||  S100 and NTRK Staining to Report NTRK Fusion Sarcoma of the Cervix (LACC 403 B) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_156;    
    Please login to see additional materials. International Society of Gynecological Pathologists Pre-Meeting Material Availability: No pre-meeting materials available for this faculty
  • ||||||||||  What's new in round cell sarcomas? (LACC 408 B) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_143;    
    International Society of Gynecological Pathologists Pre-Meeting Material Availability: No pre-meeting materials available for this faculty International Society of Bone and Soft Tissue Pathology Pre-Meeting Material Availability: No pre-meeting materials available for this faculty
  • ||||||||||  Orbital Sarcomas - Learning from the Expert (LACC 407) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_116;    
    No data found. American Association of Ophthalmic Oncologists and Pathologists Pre-Meeting Material Availability: No pre-meeting materials available for this faculty
  • ||||||||||  Soft Tissue Sarcomas in the Era of the NGS Epidemics (LACC 406 AB) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_33;    
    American Association of Ophthalmic Oncologists and Pathologists Pre-Meeting Material Availability: No pre-meeting materials available for this faculty Pre-Meeting Material Availability: No pre-meeting materials available for this faculty
  • ||||||||||  Recent Advances and Updates in Histopathology - Tiniakos (LACC 405) -  Dec 3, 2019 - Abstract #USCAP2020USCAP_28;    
    Physicians should claim only the credit commensurate with the extent of their participation in the activity. The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
  • ||||||||||  Clinical, Journal:  Clinicopathological characteristics and therapeutic effects of adult rhabdomyosarcoma patients (Pubmed Central) -  Dec 3, 2019   
    Pleomorphic RMS was the main histological subtype for adult RMS patients, and the prognosis for adult RMS was usually poorer than that for pediatric RMS patients. Single therapeutic approach could not achieve satisfactory outcomes, while multimodal treatment consisted of surgery, chemotherapy and radiotherapy are helpful to improve the prognosis of adult patients with RMS.
  • ||||||||||  Danyelza (naxitamab-gqgk) - Y / mAbs Therap
    Trial completion date, Trial primary completion date:  PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study (clinicaltrials.gov) -  Dec 3, 2019   
    P=N/A,  N=7, Active, not recruiting, 
    Single therapeutic approach could not achieve satisfactory outcomes, while multimodal treatment consisted of surgery, chemotherapy and radiotherapy are helpful to improve the prognosis of adult patients with RMS. Trial completion date: Nov 2019 --> Nov 2020 | Trial primary completion date: Nov 2019 --> Nov 2020
  • ||||||||||  Journal:  Inflammatory Myofibrobalstic Tumor in Female Genital Tract. (Pubmed Central) -  Dec 2, 2019   
    - Inflammatory myofibroblastic tumor in the female genital tract can mimic other more common benign and malignant tumors like leiomyoma, leiomyosarcoma, and endometrial stromal sarcoma. Familiarity with clinical and histologic features and use of ALK immunostaining can be critical for correct diagnosis.
  • ||||||||||  Clinical, Journal:  Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population. (Pubmed Central) -  Dec 2, 2019   
    Moreover, different single nucleotide polymorphism (SNP) effects between the two populations included were observed, suggesting the existence of population differences. In conclusion, 14q32 miRNA cluster seems to be a hotspot for osteosarcoma susceptibility in the Spanish population, but not in the Slovenian, which supports the idea of the existence of population differences in developing this disease.
  • ||||||||||  Zonalta (Z-endoxifen hydrochloride) / Jina Pharma, Intas
    Trial completion date, Trial primary completion date:  Endoxifen in Adults With Hormone Receptor Positive Solid Tumors (clinicaltrials.gov) -  Dec 2, 2019   
    P1,  N=40, Active, not recruiting, 
    In conclusion, 14q32 miRNA cluster seems to be a hotspot for osteosarcoma susceptibility in the Spanish population, but not in the Slovenian, which supports the idea of the existence of population differences in developing this disease. Trial completion date: Jun 2020 --> Jun 2021 | Trial primary completion date: Jun 2020 --> Jun 2021
  • ||||||||||  Journal:  Zebras in Foreskin Dermatopathology: A Review. (Pubmed Central) -  Dec 1, 2019   
    Trial completion date: Jun 2020 --> Jun 2021 | Trial primary completion date: Jun 2020 --> Jun 2021 We reviewed and discussed unusual benign and malignant dermatopathology conditions that can affect the foreskin.